Watchlist Price Alert

Enanta Pharmaceuticals In... (ENTA)

NASDAQ: ENTA · Real-Time Price · USD

5.46

-0.49 (-8.24%)

At close: May 05, 2025, 3:59 PM

5.44

-0.37%

After-hours: May 05, 2025, 04:05 PM EDT

Enanta Pharmaceuticals Balance Sheet Statement

Financials in USD. Fiscal year is October - September.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019	Sep 30, 2018	Sep 30, 2017	Sep 30, 2016
Cash & Equivalents	37.23M	85.39M	43.99M	57.21M	87.13M	51.23M	63.9M	65.67M	16.58M
Short-Term Investments	210.95M	284.52M	205.24M	186.8M	299.52M	284.01M	244.83M	157.99M	193.51M
Long-Term Investments	n/a	n/a	29.29M	108.42M	32.63M	65.01M	16.39M	70.04M	32.12M
Other Long-Term Assets	3.45M	4.77M	4.66M	700K	700K	700K	700K	608K	608K
Receivables	6.65M	39.62M	49.04M	60.83M	23.49M	51.31M	67.2M	10.61M	12.84M
Inventory	n/a	n/a	n/a	-37.26M	n/a	n/a	n/a	n/a	n/a
Other Current Assets	45.02M	13.26M	n/a	n/a	26.7M	15.3M	4.45M	3.54M	9.23M
Total Current Assets	299.85M	422.79M	311.71M	319.02M	436.84M	401.85M	380.39M	237.82M	232.16M
Property-Plant & Equipment	73.35M	34.71M	29.75M	10.65M	15.62M	10.93M	8.37M	8.05M	8M
Goodwill & Intangibles	n/a	n/a	-5.18M	-2.07M	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	76.8M	39.48M	63.7M	119.77M	49.3M	87.98M	33.84M	88.82M	49.12M
Total Assets	376.65M	462.27M	375.41M	438.79M	486.13M	489.83M	414.23M	326.64M	281.28M
Account Payables	8M	4.1M	6M	9.54M	5.74M	6.69M	4.75M	3.71M	3.38M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	9.3M	n/a
Short-Term Debt	n/a	n/a	2.89M	4.2M	4.26M	n/a	n/a	n/a	n/a
Other Current Liabilities	48.01M	46.38M	11.61M	12.13M	5.12M	n/a	n/a	9.22M	n/a
Total Current Liabilities	57.53M	62.79M	29.83M	36.17M	24.16M	22.61M	16.02M	20.98M	7.89M
Long-Term Debt	n/a	n/a	n/a	n/a	1.48M	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	136.36M	161.51M	1.88M	2.06M	1.08M	4.53M	4.23M	3.6M	2.99M
Total Long-Term Liabilities	190.3M	182.75M	24.25M	3.19M	6.39M	4.73M	4.52M	3.98M	3.45M
Total Liabilities	247.84M	245.54M	54.08M	39.36M	30.55M	27.34M	20.55M	24.96M	11.34M
Total Debt	55.47M	26.51M	25.26M	5.33M	8.1M	200K	293K	458K	531K
Common Stock	212K	211K	208K	202K	201K	197K	194K	191K	190K
Retained Earnings	-323.04M	-207M	-73.18M	48.58M	127.57M	163.74M	117.36M	45.36M	27.65M
Comprehensive Income	302K	-1.17M	-3.72M	-382K	844K	146K	-398K	-112K	19K
Shareholders Equity	128.81M	216.74M	321.33M	399.43M	455.58M	462.49M	393.68M	301.68M	269.94M
Total Investments	210.95M	284.52M	234.52M	295.21M	332.15M	349.02M	261.22M	228.03M	225.63M